Trials
IND Enabling
Phase I
Phase II
Phase III
Recurrent or Progressive High-grade Glioma, (NCT06737146)
Sponsors:
Suzhou Maximum Bio-tech Co., Ltd.
Indicator
IND Enabling
Phase I
Phase II
Phase III
Indicator
IND Enabling
Phase I
Phase II
Phase III
Transfusion-dependent Beta- Thalassemia, (NCT06479616)
Sponsors:
Children's Hospital of Fudan University
IND Enabling
Phase I
Phase II
Phase III
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Retinitis Pigmentosa, (NCT06952842)
Sponsors:
Chigenovo Co., Ltd
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Indicator
IND Enabling
Phase I
Phase II
Phase III
Sickle Cell Disease, (NCT07000318)
Sponsors:
Children's Hospital of Fudan University
Indicator
IND Enabling
Phase I
Phase II
Phase III
close
Search CRISPR Medicine